Association of absolute lymphocyte and cd4 T cell count ratio with outcome of HIV-negative TB meningitis patients- A longitudinal study.

Pratyush  Kumar; Dr. (Prof) Deepak  Goel; Manish  Mittal; Ashwani  Bhatt

doi:10.51168/sjhrafrica.v6i6.1921

Authors

Dr. Pratyush Kumar Senior Resident, Dept of Neurology, Himalayan Institute of Medical Sciences, Dehradun, Uttarakhand, India
Dr. (Prof) Deepak Goel HOD, Dept of Neurology, Himalayan Institute of Medical sciences, Dehradun, Uttarakhand, India
Dr. Manish Mittal Professor, Dept of Neurology, Himalayan Institute of Medical sciences, Dehradun, Uttarakhand, India
Dr. Ashwani Bhatt Associate Professor, Dept of Neurology, Himalayan Institute of Medical sciences, Dehradun, Uttarakhand, India

DOI:

https://doi.org/10.51168/sjhrafrica.v6i6.1921

Keywords:

Tuberculous meningitis, CD4 count, Absolute lymphocyte count, HIV-negative, Outcome, Neurology, India

Abstract

Background

Tuberculous meningitis (TBM), the most severe form of tuberculosis, presents significant diagnostic and therapeutic challenges. Cellular immunity, particularly CD4+ T lymphocytes and absolute lymphocyte count (ALC), plays a critical role in host defense against Mycobacterium tuberculosis. However, the prognostic significance of ALC and CD4 counts in HIV-negative TBM patients remains underexplored in India.

Objective: To assess the association between absolute lymphocyte count and CD4 T cell count with clinical outcomes in HIV-negative TBM patients.

Methods

This was a longitudinal follow-up study conducted in the Department of Neurology, Himalayan Institute of Medical Sciences, Dehradun, over 2 years. A total of 53 HIV-negative adult TBM patients were enrolled and classified by TBM stage (I–III) and diagnostic certainty (definite, probable, possible) using MRC grading and Marais criteria, respectively.

Results

Among 53 patients, 23 were male and 30 were female. Females had significantly better outcomes (83.3% vs 47.8%, p = 0.006, RR = 2.36). Patients in earlier TBM stages had higher good outcomes: Stage I (85.7%), Stage II (78.7%), Stage III (30.7%) (p = 0.004). No statistically significant association was found between outcome and ALC (p = 0.424) or CD4 count group (p = 0.856), though trends favored better prognosis in patients with normal immune parameters. Duration of dexamethasone therapy and symptom onset also showed no significant impact on outcome.

Conclusion

While TBM stage and gender were significantly associated with clinical outcome, no definitive link was observed between ALC or CD4 count and prognosis in HIV-negative TBM patients. Further large-scale studies are warranted to validate the prognostic utility of immune markers in TBM.

Recommendations

To confirm the predictive significance of ALC and CD4 counts in HIV-negative TBM, future research should involve larger, multicenter cohorts.

References

Davoudi S, Rasoolinegad M, Younesian M, Hajiabdolbaghi M, Soudbakhsh A, Jafari S, EmadiKouchak H, Mehrpouya M, Lotfi H. CD4+ cell counts in patients with different clinical manifestations of tuberculosis. Braz J Infect Dis. 2008 Dec;12(6):483-6. https://doi.org/10.1590/S1413-86702008000600008 PMid:19287835

Al-Aska A, Al-Anazi AR, Al-Subaei SS, Al-Hedaithy MA, Barry MA, Somily AM, Buba F, Yusuf U, Al Anazi NA. CD4+ T-lymphopenia in HIV negative tuberculous patients at King Khalid University Hospital in Riyadh, Saudi Arabia. Eur J Med Res. 2011 Jun 21;16(6):285-8. https://doi.org/10.1186/2047-783X-16-6-285 PMid:21810564 PMCid:PMC3353405

Uppal SS, Tewari SC, Verma S, Dhot PS. Comparison of CD4 and CD8 lymphocyte counts in HIV-negative pulmonary TB patients with those in normal blood donors and the effect of antitubercular treatment: hospital-based flow cytometric study. Cytometry B Clin Cytom. 2004 Sep;61(1):20-6. https://doi.org/10.1002/cyto.b.20018 PMid:15351978

Mi J, Liu Y, Xue Y, Sun W, Liang Y, Liang J, An H, Wu X. The changes and their significance of peripheral blood NK cells in patients with tuberculous meningitis. Front Microbiol. 2024 Feb 29;15:1344162. https://doi.org/10.3389/fmicb.2024.1344162 PMid:38486698 PMCid:PMC10937341

Feng JY, Huang SF, Ting WY, Chen YC, Lin YY, Huang RM, Lin CH, Hwang JJ, Lee JJ, Yu MC, Yu KW, Lee YC, Su WJ. Gender differences in treatment outcomes of tuberculosis patients in Taiwan: a prospective observational study. Clin Microbiol Infect. 2012 Sep;18(9):E331-7. doi: 10.1111/j.1469-0691.2012.03931.x. Epub 2012 Jun 27. PMID: 22734962.https://doi.org/10.1111/j.1469-0691.2012.03931.x PMid:22734962

Wang MG, Luo L, Zhang Y, Liu X, Liu L, He JQ. Treatment outcomes of tuberculous meningitis in adults: a systematic review and meta-analysis. BMC Pulm Med. 2019 Nov 6;19(1):200. Doi: 10.1186/s12890-019-0966-8. PMID: 31694599; PMCID: PMC6833188.

Gupta R, Kushwaha S, Thakur R, Jalan N, Rawat P, Gupta P, Aggarwal A, Gupta M, Manchanda V. Predictors of adverse outcome in patients of tuberculous meningitis in a multi-centric study from India. Indian J Tuberc. 2017 Oct;64(4):296-301. https://doi.org/10.1016/j.ijtb.2017.03.001 PMid:28941852